Sort   by:  
 Page size 
ProteomicsRepurposing of Amisulpride, a known antipsychotic drug, to target synovial fibroblasts activation in arthritis.
Synovial Fibroblasts (SFs) are key pathogenic drivers in arthritis and their in vivo activation by TNF is sufficient to orchestrate full arthritic pathogenesis in animal models. TNF blockade has been efficacious for a large percentage of Rheumatoid Arthritis (RA) patients, although characterized by ...
ORGANISM(S): Mus musculus (Mouse) 
2023-04-06 | PXD036283 | Pride
Rheumatoid arthritis Amisulpride Repurposing Synovial fibroblasts Chemical proteomics Click-chemistry 
GenomicsRepurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis II
Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis II
PRJNA869078 | ENA
GenomicsRepurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis I
Repurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis I
PRJNA869070 | ENA
TranscriptomicsRepurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis II
Amisulpride, a known antipsychotic drug, was identified to target synovial fibroblasts activation in arthritis through novel identified targets.
ORGANISM(S): Mus musculus 
2023-04-06 | GSE211137 | GEO
TranscriptomicsRepurposing the antipsychotic drug amisulpride for targeting synovial fibroblast activation in arthritis I
Amisulpride, a known antipsychotic drug, was identified to target synovial fibroblasts activation in arthritis through novel identified targets.
ORGANISM(S): Mus musculus 
2023-04-06 | GSE211132 | GEO
UnknownAmisulpride withdrawal dyskinesia: a case report.
Not available
S-EPMC5471910 | biostudies-literature
UnknownAmisulpride versus other atypical antipsychotics for schizophrenia.
Not available
S-EPMC4164462 | biostudies-literature
TranscriptomicsBlood methylomes of the first-episode schizophrenia patients differing in their response to amisulpride treatment (OPTiMiSE cohort)
Blood methylomes of the first-episode schizophrenia patients differing in their response to amisulpride treatment (OPTiMiSE cohort)
ORGANISM(S): Homo sapiens 
2024-12-30 | E-MTAB-13006 | biostudies-arrayexpress
UnknownMetabolism and Excretion of Intravenous, Radio-Labeled Amisulpride in Healthy, Adult Volunteers.
Not available
S-EPMC6896931 | biostudies-literature
UnknownInteraction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer's disease.
Not available
S-EPMC10597500 | biostudies-literature
Sort   by:  
 Page size